Verve Therapeutics Inc (VERV)
13.19
+0.40
(+3.13%)
USD |
NASDAQ |
Mar 27, 16:00
13.18
-0.01
(-0.08%)
Pre-Market: 08:27
Verve Therapeutics Revenue (TTM): 11.76M for Dec. 31, 2023
Revenue (TTM) Chart
Historical Revenue (TTM) Data
Date | Value |
---|---|
December 31, 2023 | 11.76M |
September 30, 2023 | 7.626M |
Date | Value |
---|---|
June 30, 2023 | 5.438M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
5.438M
Minimum
Jun 2023
11.76M
Maximum
Dec 2023
8.274M
Average
7.626M
Median
Sep 2023
Revenue (TTM) Benchmarks
Intellia Therapeutics Inc | 36.28M |
Beam Therapeutics Inc | 377.71M |
Editas Medicine Inc | 78.12M |
Moderna Inc | 6.754B |
Ionis Pharmaceuticals Inc | 787.65M |